Prothena | PRTA - Ordinary Share Capital

Prothena reported $521K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Exelixis EXEL:US USD 324K 1000
Intercept Pharmaceuticals ICPT:US USD 42K 1000
Intra Cellular Therapies ITCI:US USD 9K 0
IONIS PHARMACEUT IONS:US USD 142K 0
Macrogenics MGNX:US USD 617K 2K
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Prothena PRTA:US USD 521K 42K
Seattle Genetics SGEN:US USD 187K 2K
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vital Therapies VTL:US USD 4K 1000
YTE INCY:US USD 223K 1000